심전계(ECG) 시장 : 제품별, 리드 유형별, 최종사용자별, 지역별(2025-2033년)

The global electrocardiograph (ECG) market size reached USD 10.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.3 Billion by 2033, exhibiting a growth rate (CAGR) of 4.32% during 2025-2033. The market growth is majorly driven by the rising healthcare awareness, technological advancements, and increasing prevalence of cardiovascular diseases. Moreover, the amplifying demand for enhanced diagnostic accuracy, portable ECG devices, and rapid development of healthcare infrastructure, particularly in emerging economies, further expands market.

An electrocardiograph (ECG) records the electrical activity of the heart by measuring its surface potentials. With this painless, noninvasive procedure, it is possible to diagnose heart problems like arrhythmias and coronary artery disease, and the effectiveness of certain heart disease treatments. By conducting surface potentials from metal contacts called electrodes to an instrument, the electrical activity of the heart can be measured on the surface of the skin. A machine that measures ECGs is connected to these electrodes through cables that are placed on the chest, lower arms, and calves. ECG graphs are generated by the machine through the conversion of signals, whereas in some cases, they can also be printed. The use of ECG monitoring devices, such as resting ECGs, stress ECGs, and Holter monitors, can provide information about abnormal heart function.

Electrocardiograph (ECG) Market Trends:

The global market is majorly driven by the rising prevalence of cardiovascular diseases, such as ischemic heart disease (IHD), hypertensive heart disease, stroke, and peripheral artery diseases, among the masses. This can be attributed to the growing geriatric population that is susceptible to developing these diseases. In line with this, continual technological advancements in ECG devices, such as innovative designs and additional features, are providing an impetus to the market. Moreover, favorable government initiatives, along with supportive reimbursement policies, are creating a positive outlook for the market. Apart from this, the advent of portable ECG systems and remote monitoring devices with a single lead is impacting the market positively. The market is further propelled by the extensive research and development (R&D) activities conducted by key players to improve healthcare infrastructure. Some of the other factors contributing to the market growth include the rising trend of medical device miniaturization and the increasing medical expenditure.

Key Market Segmentation:

Breakup by Product:

• Resting Electrocardiograph (ECG)
• Stress Electrocardiograph (ECG)
• Holter Monitors
• Others

Breakup by Lead Type:

• Single Lead ECG
• 2 Lead ECG
• 3 Lead ECG
• 6 Lead ECG
• 12 Lead ECG

Breakup by End User:

• Hospitals and Clinics
• Home Settings and Ambulatory Surgical Centers (ASCs)
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AliveCor Inc., Allengers Medical Systems Limited, BPL Medical Technologies, CompuMed Inc., Fukuda Denshi Co. Ltd., General Electric Company, Hill-Rom Holdings Inc. (Baxter International Inc.), Innomed Medical Inc., Koninklijke Philips N.V., Midmark Corporation, Nihon Kohden Corporation, OSI Systems Inc., Schiller AG and Shenzhen Mindray Bio-Medical Electronics Co. Ltd.

Key Questions Answered in This Report

• 1.What was the size of the global Electrocardiograph (ECG) market in 2024?
• 2.What is the expected growth rate of the global Electrocardiograph (ECG) market during 2025-2033?
• 3.What are the key factors driving the global Electrocardiograph (ECG) market?
• 4.What has been the impact of COVID-19 on the global Electrocardiograph (ECG) market?
• 5.What is the breakup of the global Electrocardiograph (ECG) market based on the product?
• 6.What is the breakup of the global Electrocardiograph (ECG) market based on the lead type?
• 7.What is the breakup of the global Electrocardiograph (ECG) market based on the end user?
• 8.What are the key regions in the global Electrocardiograph (ECG) market?
• 9.Who are the key players/companies in the global Electrocardiograph (ECG) market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Electrocardiograph (ECG) Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Resting Electrocardiograph (ECG)
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Stress Electrocardiograph (ECG)
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Holter Monitors
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Lead Type

• 7.1 Single Lead ECG
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 2 Lead ECG
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 3 Lead ECG
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 6 Lead ECG
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 12 Lead ECG
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals and Clinics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Home Settings and Ambulatory Surgical Centers (ASCs)
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 AliveCor Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Allengers Medical Systems Limited
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 BPL Medical Technologies
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 CompuMed Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
  • 14.3.5 Fukuda Denshi Co. Ltd.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 General Electric Company
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Hill-Rom Holdings Inc. (Baxter International Inc.)
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 SWOT Analysis
  • 14.3.8 Innomed Medical Inc.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Koninklijke Philips N.V.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Midmark Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Nihon Kohden Corporation
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 OSI Systems Inc.
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis
  • 14.3.13 Schiller AG
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio
  • 14.3.14 Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
    • 14.3.14.1 Company Overview
    • 14.3.14.2 Product Portfolio
    • 14.3.14.3 Financials
    • 14.3.14.4 SWOT Analysis